Search

Search Results
Results 16631 - 16640 of 17732 for Depression
  • Drug - 31 May 2024
    Consumer Medicine Information (CMI) about Actrapid Vial, Protaphane Vial (insulin) intended for persons living in Australia.
  • Drug - 31 May 2024
    Consumer Medicine Information (CMI) about Actrapid, Protaphane, Mixtard 30/70, Mixtard 50/50 (insulin) intended for persons living in Australia.
  • Drug - 31 May 2024
    Consumer Medicine Information (CMI) about Zeldox Capsules intended for persons living in Australia.
  • Drug - 22 May 2024
    Consumer Medicine Information (CMI) about Oruvail SR intended for persons living in Australia.
  • Drug - 22 May 2024
    Consumer Medicine Information (CMI) about Orudis SR intended for persons living in Australia.
  • Drug - 15 May 2024
    Consumer Medicine Information (CMI) about Trisequens (Estradiol/Norethisterone acetate) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Kliovance (Estradiol/Norethisterone acetate) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Kliogest (Estradiol/Norethisterone acetate) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Estrofem (Estradiol) intended for persons living in Australia.
  • Drug - 29 Apr 2024
    Consumer Medicine Information (CMI) about Levemir FlexPen (insulin detemir) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.